rv function in congenital heart diseases and …...rv function in congenital heart diseases and...

41
Ruxandra Jurcut RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy “Carol Davila” Bucharest, Romania Declaration of conflict of interest: none to declare

Upload: others

Post on 30-May-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Ruxandra Jurcut

RV function in

congenital heart diseases and

pulmonary hypertension

Department of Cardiology

University of Medicine and Pharmacy “Carol Davila”

Bucharest, Romania

Declaration of conflict of interest: none to declare

Page 2: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Agenda

Background

RV – complex anatomy & function

Specific question

RV myocardial function in PH and

congenital heart disease = RV in different

loading conditions

deformation imaging and loading conditions

Take home messages

Page 3: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RV remodeling

The RV and LV differ markedly in their anatomy, mechanics, and

loading conditions:

Structure: crescent-shaped, thin-walled RV

Hemodynamics: volume pump, ejecting in a low-resistance pulmonary

arterial circulation.

Special contraction pattern – peristaltic movement

87% from the RV stroke volume – RV sinus (apical 4CV)

80% from the RV stroke volume - longitudinal contraction

Page 4: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RV remodeling/failure and prognosis

PHT and RV failure - strong predictors of mortality in

LV failure, AMI and COPD

RV dysfunction is a strong prognostic factor in:

PulmReg postrepair for Tetralogy of Fallot

systemic RV in TGA

PH (TAPSE only)…

RV pressure overload associated with pulmonary valve

stenosis - better prognosis than PAH

Page 5: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Load and contractility

Bijnens et al EJE 2008

Page 6: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Cardiac mechanics –

how is it balanced?

Page 7: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Frank Starling law

LVEDP (mmHg) LVEDP (mmHg)

SV

(m

l)

SV

(m

l)

↑ afterload

↓ inotropy

↓ afterload

↑ inotropy

Page 8: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Load, geometry and contractility

Laplace’s law

Page 9: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RV function assessment

Gold standard: pressure-volume loops

Load dependence of dp/dt, stroke work

Load independence of end systolic elastance, PRSW

Bleeker, Heart 2006

Page 10: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Myocardial deformation imaging –

several techniques, several parameters

t

t

IVV

IVA=IVV/t

Jurcut et al, Eur J Echo 2010

Page 11: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Load and contractility – in practice

Rosner et al, EJE 2008

Page 12: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RV deformation

Afterload alterations

Pulmonary hypertension

Pulmonary stenosis

Transposition of the great arteries

(“systemic RV”)

Preload alterations

Atrial septal defect

Tricuspid regurgitation

Pulmonary regurgitation

Page 13: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Pulmonary Hypertension

Puwanant et al, Circulation 2010

PASP LVEI

Page 14: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Pulmonary Hypertension

Puwanant et al, Circulation 2010

PASP LVEI

Page 15: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Pulmonary Hypertension

Simon et al, Congest Heart Fail 2009

-26±1%

-19±1%

-14±1%

Study group RV FW LS

ROC curve cutoff

Sn Sp

Normal PAPs ≤ -27.2% 70% 93.5%

PH compensated vs decompensated ≥ -14.9% 61.5% 85%

RAP<10 mmHg RAP>10 mmHg

* * #

Page 16: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Increased afterload: PHT vs PStenosis

Jurcut et al, JASE 2011

RVP

73±34 mmHg

RVP

88±31 mmHg

RVP

25±4 mmHg

p = 0.37

p<0.001

Page 17: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Arterial PHT

F, 25 years

RVP = 100 mmHg

Pulmonary stenosis

F, 27 years

RVP = 106 mmHg

Page 18: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Increased afterload: PHT vs PStenosis

Jurcut et al, JASE 2011

Page 19: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Pulmonary artery banding ~

PulmSten

Angioproliferative pulmonary

vascular remodeling ~ aPHT

Bogaard et al, Circulation 2009

PS PHT

Page 20: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RV and PH etiology – does it matter?

48 patients PH

14 pts iPAH

42±14 yo

7 pts PH assoc CTD

53±15 yo

16 pts CTEPH

53±12 yo

11 pts Eisenmenger

41±16 yo

pVarsta = NS Giusca, Jurcut et al, data on file

Page 21: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Similar sPAP…

iPAH PH_CTD CTEPH EisenSy

sPAP (mmHg) 96±36 72±12.5 89±12 96±14

PANOVA=0.1

HTPAI HTP_BTC HTPTC Sindr Eisen.0

50

100

150

200

PA

Ps (

mm

Hg

)

Giusca, Jurcut et al, data on file

Page 22: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

…but different RV morphology…

Grosimea perete VD

HTPAI HTP_BTC HTPTC Sind Eisen0.0

2.5

5.0

7.5

10.0

GP

VD

(m

m)

Pposthoc <0.05 Pposthoc <0.01 PANOVA=0.002

RVfw 7,6±1,8 6,2±1,2 7,2±1,4 9,2±1,5

Diametru telediastolic VD

HTPAI HTP_BTC HTPTC Sindr Eisen.0

10

20

30

40

50

DT

VD

(m

m)

Pposthoc <0.05 Pposthoc <0.05 PANOVA=0.04

RVEDD 45,9±10 36,6±6 47,9±6 43±10,8

Giusca, Jurcut et al, data on file

Page 23: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RVEDA RVESA

Rata de modificare a ariei VD

HTPAI HTP_BTC HTPTC Sindr Eisen.0

5

10

15

20

25

30

35

40

45

RV

FA

C (

%)

PANOVA=0.005

Pposthoc <0.05

Pposthoc <0.05

Pposthoc <0.01

areaicenddiastolRV

areacendsystoliRVareaicenddiastolRVRVFAC

RVFAC 30,9±10 27,5±11 27,5±9,5 41±8,9

…and different RV function

Giusca, Jurcut et al, data on file

Page 24: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Pposthoc <0.05

PANOVA=0.007

Long S (%) -15,6±6,8 -17,4±6,8 -12,6±4,8 -20,6±3,5

Strain la nivelul perete liber VD

HTPAI HTP_BTC HTPTC Sindr Eisen.

-30

-20

-10

0

Str

ain

(%

)

Pposthoc <0.05

…and different RV function

Free RV wall longitudinal strain

Giusca, Jurcut et al, data on file

Page 25: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Is RV adaptation/remodeling identical for all PH forms?

And what does it mean?

Eisenmenger Syndrome

iPAH

CTEPH

Hopkins et al, Coronary Artery Disease 2005

So…

Page 26: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

However, also in Eisenmenger syndrome…

Van de Bruaene et al, Am J Cardiol 2012

Page 27: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Eisenmenger syndrome

– linking echo to prognosis

Van de Bruaene et al, Am J Cardiol 2012

Page 28: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

TGA – the “systemic right ventricle”

Page 29: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

TGA – the “systemic right ventricle”

Pettersen et al, JACC 2007

Page 30: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

TGA – the “systemic right ventricle”

Di Salvo et al, Int J Cardiol 2010

Page 31: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

TGA – the “systemic right ventricle”

Di Salvo et al, Int J Cardiol 2010

Page 32: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Atrial septal defect

Page 33: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Open atrial septal defect

*

Jategaonkar et al, EJE 2009

Page 34: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Atrial septal defect – open vs closed

Van de Bruaene et al, EJE 2011

Page 35: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Van de Bruaene et al, Eur J Prev Cardiol 2012

Atrial septal defect – exercise physiology

Page 36: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RV function after ToF repair

•Different echocardiographic techniques have

become available that allow to reliably and

accurately assess RV volumes and function.

• Both 3D an 3DR can be used in

postoperative pediatric patients after TOF

correction.

• Cardiac MRI currently still is the reference

technique.

Dragulescu et al, Eur J Echo 2011

Page 37: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Eyskens et al, Eur J Echocard 2010

RV function after ToF repair

Page 38: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Eyskens et al, Eur J Echocard 2010

RV function after ToF repair

Page 39: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

RV function after ToF repair

Dragulescu et al, Euroecho 2011

In patients after ToF repair, RV dilatation due to chronic

Pulm Reg is associated with reduced strain.

Page 40: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Take home messages

Page 41: RV function in congenital heart diseases and …...RV function in congenital heart diseases and pulmonary hypertension Department of Cardiology University of Medicine and Pharmacy

Interpretation of MDI parameters must always

incorporate loading conditions:

Influence of volume vs pressure overload

Influence of geometrical changes (e.g.RV dilation)

RV function may not be adequately described by

longitudinal function alone.

RV myocardial adaptation to load in different conditions:

RV wall transverse fibers hypertrophy with increased afterload

Different cellular and molecular adaptation mechanisms to

pressure overload (e.g. PS vs PHT)

Take home messages